BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37276643)

  • 1. Fluoxetine inactivates STAT3/NF-κB signaling and promotes sensitivity to cisplatin in bladder cancer.
    Yang CJ; Tan ZL; Yang JD; Hsu FT; Chiang CH
    Biomed Pharmacother; 2023 Aug; 164():114962. PubMed ID: 37276643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
    Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
    Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lenvatinib Synergistically Promotes Radiation Therapy in Hepatocellular Carcinoma by Inhibiting Src/STAT3/NF-κB-Mediated Epithelial-Mesenchymal Transition and Metastasis.
    Weng YS; Chiang IT; Tsai JJ; Liu YC; Hsu FT
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):719-732. PubMed ID: 36245124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro.
    Chen WT; Hsu FT; Liu YC; Chen CH; Hsu LC; Lin SS
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
    Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
    Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chalepin: A Compound from
    Richardson JSM; Aminudin N; Abd Malek SN
    Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S489-S498. PubMed ID: 29142404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synergistic interaction between transcription factors nuclear factor-κB and signal transducers and activators of transcription 3 promotes gastric cancer cell migration and invasion.
    Yoon J; Cho SJ; Ko YS; Park J; Shin DH; Hwang IC; Han SY; Nam SY; Kim MA; Chang MS; Lee HS; Kim WH; Lee BL
    BMC Gastroenterol; 2013 Feb; 13():29. PubMed ID: 23402362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.
    Han SS; Yun H; Son DJ; Tompkins VS; Peng L; Chung ST; Kim JS; Park ES; Janz S
    Mol Cancer; 2010 Apr; 9():97. PubMed ID: 20433747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine Inhibits STAT3-mediated Survival and Invasion of Osteosarcoma Cells.
    Chen WT; Tsai YH; Tan P; Hsu FT; Wang HD; Lin WC; Lin FH; Wu CT
    Anticancer Res; 2023 Mar; 43(3):1193-1199. PubMed ID: 36854535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-κB-modulated tumor progression in bladder cancer in vitro and in vivo.
    Chiang CH; Chung JG; Hsu FT
    Environ Toxicol; 2019 Jun; 34(6):679-688. PubMed ID: 30801954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Efficacy and Mechanism of Amentoflavone for Sensitizing Oral Squamous Cell Carcinoma to Cisplatin.
    Chen CH; Huang YC; Lee YH; Tan ZL; Tsai CJ; Chuang YC; Tu HF; Liu TC; Hsu FT
    Anticancer Res; 2020 Dec; 40(12):6723-6732. PubMed ID: 33288565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rh1 Prevents Migration and Invasion through Mitochondrial ROS-Mediated Inhibition of STAT3/NF-κB Signaling in MDA-MB-231 Cells.
    Jin Y; Huynh DTN; Myung CS; Heo KS
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling.
    Wu Q; Zhou X; Li P; Ding M; You S; Xu Z; Ye J; Chen X; Tan M; Wang J; Wang W; Qiu J
    J Exp Clin Cancer Res; 2021 May; 40(1):158. PubMed ID: 33962660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model.
    Hsu LC; Tu HF; Hsu FT; Yueh PF; Chiang IT
    Biomed Pharmacother; 2020 Jun; 126():110054. PubMed ID: 32145588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-κB signalling participate in anti-glioblastoma of imipramine.
    Hsu FT; Chiang IT; Wang WS
    J Cell Mol Med; 2020 Apr; 24(7):3982-4000. PubMed ID: 32149465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnolol Induces Apoptosis Through Extrinsic/intrinsic Pathways and Attenuates NF-κB/STAT3 Signaling in Non-small-cell Lung Cancer Cells.
    Lee YC; Weng YS; Wang HY; Hsu FT; Chueh FS; Wu JY; Chen WL; Chen JH
    Anticancer Res; 2022 Aug; 42(8):3825-3833. PubMed ID: 35896265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperforin Induces Apoptosis Through Extrinsic/Intrinsic Pathways and Inhibits NF-ĸB-modulated Survival and Invasion Potential in Bladder Cancer.
    Liu YC; Lin KH; Hsieh JH; Chung JG; Tan ZL; Hsu FT; Chiang CH
    In Vivo; 2019; 33(6):1865-1877. PubMed ID: 31662514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
    Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z
    Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways.
    Pan Q; Yang GL; Yang JH; Lin SL; Liu N; Liu SS; Liu MY; Zhang LH; Huang YR; Shen RL; Liu Q; Gao JX; Bo JJ
    J Exp Clin Cancer Res; 2015 Aug; 34(1):77. PubMed ID: 26245871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.